Hemopatch®, A New Generation Dural Sealant in Neurosurgery; Our Clinical Experience





CSF fistula, dural closure, hemopatch


Cerebrospinal fluid (CSF) fistula is an important complication in neurosurgery. A literature review was performed with the use of Hemopatch® in cranial surgery together with fibrin glue. Early and late postoperative results of 4 patients who were operated for an intracranial mass and used Hemopatch® with fibrin glue in the dural closure of CSF leak stage were evaluated. The mean age of the patients was 62.25 ± 10.49 years and the mean follow-up period was 16.25 ± 3.27 weeks. All of the patients who used fibrin glue Hemopatch® consisted of patients who had undergone cranial surgery (75% was pterional craniotomy, 25% was retrosigmoid craniotomy). Cerebrospinal Fluid (CSF) leakage occurred in the early post-operative period in 1 patient who underwent Hemopatch® by completely removing the dural layer due to extensive dural invasion and performing duraplasty with fascia after the follow-up. Hemopatch was applied and CSF leakage was not observed in the other 3 patients with small dural defects. In conclusion, we first demonstrated the feasibility and safety of using Hemopatch® as a dural sealant in fibrin glued cranial surgery.


Download data is not yet available.


Metrics Loading ...



How to Cite

Boyalı O, Özdemir Ömer, Diren F, Cesur F, Çetin E, Taş N, Uçar S, Chasan M, Kabataş S, Civelek E. Hemopatch®, A New Generation Dural Sealant in Neurosurgery; Our Clinical Experience. J Nervous Sys Surgery [Internet]. 2022 Sep. 15 [cited 2023 Mar. 24];8(2):73-7. Available from: https://sscdergisi.org/index.php/sscd/article/view/212



Research Article